BIOMAT Database Logo BIOMAT Database Logo

The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression. 1982

J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression.
March 1980, Life sciences,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
January 1997, Voprosy meditsinskoi khimii,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report.
January 2005, Clinical neuropharmacology,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation.
May 1983, The British journal of psychiatry : the journal of mental science,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'.
April 1978, Psychopharmacology,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitor.
January 1984, New York state journal of medicine,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (-)-deprenyl research.
January 1996, Journal of neural transmission. Supplementum,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
Pharmacological actions of l-deprenyl (selegiline) and other selective monoamine oxidase B inhibitors.
December 1994, Clinical pharmacology and therapeutics,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
The effect of deprenyl, a selective monoamine oxidase B inhibitor, on sleep and mood in man.
January 1980, Psychopharmacology,
J J Mann, and A Frances, and R D Kaplan, and J Kocsis, and E D Peselow, and S Gershon
Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
January 1981, Psychopharmacology,
Copied contents to your clipboard!